FDA Person
FDAJessica Mu
View detailed information about Jessica Mu, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Jessica Mu, including their role, qualifications, and regulatory activities.
Recent Records (14)
WARNING_LETTER - Red Oak Instruments, LLC
WARNING_LETTER
WARNING_LETTER - San Diego Compounding Pharmacy
WARNING_LETTER
WARNING_LETTER - Precise Nutrition International, Inc.
WARNING_LETTER
STATE_REFERRAL_LETTER - Unknown Company
STATE_REFERRAL_LETTER
WARNING_LETTER - Pinnacle Labs International, Inc.
WARNING_LETTER
WARNING_LETTER - ImprimisRx CA, Inc., dba ImprimisRx
WARNING_LETTER
483_RESPONSE - Custom Compounding Centers, LLC
483_RESPONSE
STATE_REFERRAL_LETTER - BBS Pharmacy, Inc. dba B&B Pharmacy
STATE_REFERRAL_LETTER
STATE_REFERRAL_LETTER - Prescription Lab Compounding Pharmacy
STATE_REFERRAL_LETTER
STATE_REFERRAL_LETTER - Professional Partners, Inc./ Westcliff Compounding Pharmacy
STATE_REFERRAL_LETTER
STATE_REFERRAL_LETTER - ImprimisRx CA, Inc., dba ImprimisRx
STATE_REFERRAL_LETTER
STATE_REFERRAL_LETTER - Custom Compounding Centers, LLC
STATE_REFERRAL_LETTER
STATE_REFERRAL_LETTER - San Diego Compounding Pharmacy
STATE_REFERRAL_LETTER
WARNING_LETTER - EEG Info
WARNING_LETTER
Person Information
Name
Jessica Mu
Title
Ms.
Role
Regulatory Personnel
ID: d08ec6ba-0ca4-41db-80b7-47727a52c321
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.